|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500112508 |
|
最近更新日期: Date of Last Refreshed on: |
2025-11-14 17:26:03 |
|
注册时间: Date of Registration: |
2025-11-14 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
ICU机械通气患者目标导向早期活动方案的实证研究 |
|
Public title: |
An empirical study of goal-oriented early activity program for patients with mechanical ventilation in ICU |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于湿太华研究应用模式下ICU机械通气患者目标导向早期活动方案的实践研究 |
|
Scientific title: |
A practical study of goal-oriented early activity program for ICU mechanical ventilation patients based on Wet-Taihua research application model |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张婉竹 |
研究负责人: |
米洁 |
|
Applicant: |
Wan-Zhu Zhang |
Study leader: |
Jie Mi |
|
申请注册联系人电话: Applicant telephone: |
+86 157 0307 7735 |
研究负责人电话:
Study leader's |
+86 139 8319 9232 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
431134721@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
986457073@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
重庆医科大学 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
重庆市渝中区重庆医科大学袁家岗校区 |
研究负责人通讯地址: |
重庆市渝中区袁家岗友谊路1号 |
|
Applicant address: |
Yuanjiagang Campus, Chongqing Medical University, Yuzhong District, Chongqing City |
Study leader's address: |
No. 1, Yuanjiagang Youyi Road, Yuzhong District, Chongqing |
|
申请注册联系人邮政编码: Applicant postcode: |
400016 |
研究负责人邮政编码: Study leader's postcode: |
400016 |
|
申请人所在单位: |
重庆市渝中区重庆医科大学袁家岗校区 |
||
|
Applicant's institution: |
Yuanjiagang Campus, Chongqing Medical University, Yuzhong District, Chongqing City |
||
|
研究负责人所在单位: |
重庆医科大学附属第一医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Chongqing Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023年科研伦理(2023-221) |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
重庆医科大学附属第一医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of Chongqing Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-07-12 00:00:00 | ||
|
伦理委员会联系人: |
严青 |
||
|
Contact Name of the ethic committee: |
Qing Yan |
||
|
伦理委员会联系地址: |
重庆市渝中区袁家岗友谊路1号 |
||
|
Contact Address of the ethic committee: |
No. 1, Yuanjiagang Youyi Road, Yuzhong District, Chongqing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 89011876 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
重庆医科大学附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Chongqing Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
重庆市渝中区袁家岗友谊路1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 1, Yuanjiagang Youyi Road, Yuzhong District, Chongqing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
课题组经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Research group funds |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
促进早期活动在ICU机械通气患者中的应用,改善ICU机械通气患者的预后,提高其生存质量。 |
||||||||||||||||||||||
|
Objectives of Study: |
Promote the application of early activity in ICU mechanically ventilated patients, improve the prognosis of ICU mechanically ventilated patients, and improve their quality of life. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.ICU机械通气的患者; 2.年龄>=18岁; 3.血流动力学和呼吸功能稳定(机械通气>24h); 4.没有严重的视觉或听觉障碍; 5.意识清醒,配合研究; 6.知情同意,自愿参与本研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients with mechanical ventilation in ICU; 2.Age>=18 years old; 3.Hemodynamics and respiratory function were stable (mechanical ventilation >24h); 4. No severe visual or hearing impairment; 5.be conscious and cooperate with research; 6.Informed consent, voluntary participation in this study. |
||||||||||||||||||||||
|
排除标准: |
1.GCS评分<=5 分; 2.有认知功能、视听觉功能障碍; 3.骨科不能搬动或移动的患者; 4.二次插管或二次入ICU; 5.院外已接受有创机械通气>=48h; 6.不可好转的疾病,预计6个月死亡率 >=50%; 7.重度心力衰竭、需要使用静脉升压药或高血压未得到控制等血流动力学不稳定患者; 8.肺栓塞、深静脉血栓等需要制动患者,血液系统疾病患者; 9.四肢残缺,椎体骨折或不稳定多发骨折等外伤患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.GCS score <=5 points; 2.Have cognitive function, visual and auditory dysfunction; 3. Patients whose orthopedics cannot be moved or moved; 4.Second intubation or second admission to ICU; 5. Outside the hospital has received invasive mechanical ventilation>=48h; 6.For diseases that cannot be improved, the mortality rate within 6 months is expected to be>=50%; 7.Hemodynamically unstable patients with severe heart failure, need to use intravenous pressors or uncontrolled hypertension; 8.Pulmonary embolism, deep vein thrombosis and other patients who need to stop, patients with blood system diseases; 9.Patients with injuries such as limb mutilation, vertebral fractures or unstable multiple fractures. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-08-01 00:00:00至 To 2024-08-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-08-01 00:00:00 至 To 2024-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
原始数据(包括元数据与研究方案)将在研究完成后6个月内上传至国家生物信息中心(National Genomics Data Center, NGDC),网址为 https://ngdc.cncb.ac.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The raw data (including metadata and study protocols) will be uploaded to the National Genomics Data Centre (NGDC) within six months of the study's completion. The website is https://ngdc.cncb.ac.cn. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统(Electronic Data Capture, EDC) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic Data Capture, EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |